World Bleeding Disorders Registry
Condition(s) studied
Study summary
The WBDR is an international observational disease registry of patients with hemophilia. It will provide a platform for a network of hemophilia treatment centres (HTCs) around the world to collect uniform and standardized patient data and guide clinical practice. With informed consent from the patient, the WBDR stores anonymous data about the person's disease, such as hemophilia type and severity, symptoms, and treatment.
Eligibility
Primary outcome measure(s)
- Number of participants recruited — 5 years
- Number of participating Hemophilia Treatment Centres — 5 years
- Number of participating countries — 5 years
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| World Federation of Hemophilia | Montreal | Quebec | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03327779 on ClinicalTrials.gov ↗ ← All trials in Canada